Combined Use of Laser Capture Microdissection and cDNA Microarray Analysis Identifies Locally Expressed Disease-Related Genes in Focal Regions of Psoriasis Vulgaris Skin Lesions

Psoriasis vulgaris is a complex disease characterized by alterations in growth and differentiation of epidermal keratinocytes as well as marked increase in leukocyte populations. Lesions are known to contain alterations in mRNAs encoding more than 1000 products, but only a very small number of these transcripts have been localized to specific cell types or skin regions. In this study, we used laser capture microdissection (LCM) and gene array analysis to study the gene expression of cells in lesional epidermis and dermis, compared with corresponding non-lesional resions. Using this approach, we detected >1800 differentially expressed gene products in the epidermis or dermis of psoriasis lesions. These results established sets of genes that are differentially expressed between epidermal and dermal compartments, as well as between non-lesional and lesional psoriasis skin. One of our findings involved the local production of CCL19, a lymphoid organizing chemokine, and its receptor CCR7 in psoriatic dermal aggregates, along with the presence of gene products LAMP3/DC-LAMP and CD83, which typify mature DCs. Gene expression patterns obtained with LCM and microarray analysis along with T cell and DC detection by immune staining suggest a possible mechanism for lymphoid organization via CCL19/CCR7 in diseased skin.

[1]  Zhifu Sun,et al.  Impact of sample acquisition and linear amplification on gene expression profiling of lung adenocarcinoma: laser capture micro-dissection cell-sampling versus bulk tissue-sampling , 2009, BMC Medical Genomics.

[2]  K. Kragballe,et al.  Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. , 2003, The Journal of investigative dermatology.

[3]  H. Takahashi,et al.  Transcriptional factor AP-2gamma increases human cystatin A gene transcription of keratinocytes. , 2000, Biochemical and biophysical research communications.

[4]  Mayte Suárez-Fariñas,et al.  Harshlight: a "corrective make-up" program for microarray chips , 2005, BMC Bioinformatics.

[5]  Andrew Johnston,et al.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. , 2010, The Journal of investigative dermatology.

[6]  F. Marincola,et al.  Complementary techniques: RNA amplification for gene profiling analysis. , 2007, Advances in experimental medicine and biology.

[7]  Thomas K. Wolfgruber,et al.  Tandem repeats derived from centromeric retrotransposons , 2013, BMC Genomics.

[8]  J. D. Engel,et al.  Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Scott B. Dewell,et al.  Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes , 2011, The Journal of investigative dermatology.

[10]  P. Wangemann,et al.  Microarray-based comparison of three amplification methods for nanogram amounts of total RNA. , 2005, American journal of physiology. Cell physiology.

[11]  N. J. Eungdamrong,et al.  Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. , 2010, The Journal of allergy and clinical immunology.

[12]  J. Segre,et al.  Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3 , 2006, The Journal of cell biology.

[13]  S. Pai,et al.  GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation , 2009, Nature Reviews Immunology.

[14]  Lisa C. Zaba,et al.  Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses , 2007, The Journal of experimental medicine.

[15]  S. Werner,et al.  Nrf2 Transcription Factor, a Novel Target of Keratinocyte Growth Factor Action Which Regulates Gene Expression and Inflammation in the Healing Skin Wound , 2002, Molecular and Cellular Biology.

[16]  J. Krueger,et al.  Increased JunB mRNA and protein expression in psoriasis vulgaris lesions. , 2006, The Journal of investigative dermatology.

[17]  R. Clark,et al.  Response to Comment on “The Vast Majority of CLA+ T Cells Are Resident in Normal Skin” , 2006, The Journal of Immunology.

[18]  R. Steinman,et al.  Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Q. Tan,et al.  Extraction of high‐quality epidermal RNA after ammonium thiocyanate‐induced dermo‐epidermal separation of 4 mm human skin biopsies , 2009, Experimental Dermatology.

[20]  M. Suárez-Fariñas,et al.  Human keratinocytes' response to injury upregulates CCL20 and other genes linking innate and adaptive immunity , 2011, The Journal of investigative dermatology.

[21]  R. Clark.  Skin-resident T cells: the ups and downs of on site immunity. , 2010, The Journal of investigative dermatology.

[22]  A. Bowcock,et al.  Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. , 2001, Human molecular genetics.

[23]  A. Kihara,et al.  Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. , 2005, The Biochemical journal.

[24]  J. Meis,et al.  Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. , 1998, The Journal of investigative dermatology.

[25]  N. J. Eungdamrong,et al.  Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. , 2009, The Journal of investigative dermatology.

[26]  M. Gilliet,et al.  Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8 , 2009, The Journal of experimental medicine.

[27]  T. Toki,et al.  Molecular Cloning and Functional Characterization of a New Cap’n’ Collar Family Transcription Factor Nrf3* , 1999, The Journal of Biological Chemistry.

[28]  I. Brody.  Changes in keratinocyte maturation during wound healing. , 1988, The Journal of investigative dermatology.

[29]  Yihong Yao,et al.  Type I Interferon: Potential Therapeutic Target for Psoriasis? , 2008, PloS one.

[30]  J. Warrington,et al.  Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. , 2003, The Journal of molecular diagnostics : JMD.

[31]  J Han JM van Krieken,et al.  Macrodissection versus microdissection of rectal carcinoma: minor influence of stroma cells to tumor cell gene expression profiles , 2005, BMC Genomics.

[32]  J. Thiery,et al.  Evaluation of methods for amplification of picogram amounts of total RNA for whole genome expression profiling , 2009 .

[33]  E. Petricoin,et al.  Laser Capture Microdissection , 1996, Science.

[34]  Wing Hung Wong,et al.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. , 2003, Physiological genomics.

[35]  Mayte Suárez-Fariñas,et al.  Evaluation of the Psoriasis Transcriptome across Different Studies by Gene Set Enrichment Analysis (GSEA) , 2010, PloS one.

[36]  Lisa C. Zaba,et al.  Cellular genomic maps help dissect pathology in human skin disease. , 2008, The Journal of investigative dermatology.

[37]  J. Cyster,et al.  Differing Activities of Homeostatic Chemokines CCL19, CCL21, and CXCL12 in Lymphocyte and Dendritic Cell Recruitment and Lymphoid Neogenesis1 , 2002, The Journal of Immunology.